Proton Therapy for Pediatric Brain Tumors

  • Anita MahajanEmail author


Proton therapy is a form of charged particle radiation therapy that has potential benefits to reduce toxicities in children with brain tumors. Despite the theoretical benefits of PRT, full acceptance of this treatment modality in this patient population has not occurred. This chapter will review the history, potential benefits, current status, evidence, and future opportunities of proton therapy for children with brain tumors. It will discuss the role of PRT, the type of patients that are being treated, and where this modality may be most beneficial.


Proton therapy Late effects Neurocognitive outcomes 


  1. Amsbaugh MJ, Grosshans DR, McAleer MF, Zhu R, Wages C, Crawford CN, Palmer M, De Gracia B, Woo S, Mahajan A (2012a) Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes. Int J Radiat Oncol Biol Phys 83(5):1419–1424. doi: 10.1016/j.ijrobp.2011.10.034 CrossRefPubMedGoogle Scholar
  2. Amsbaugh MJ, Zhu XR, Palmer M, Poenisch F, McAleer MF, Mahajan A, Grosshans DR (2012b) Spot scanning proton therapy for craniopharyngioma. Pract Radiat Oncol 2(4):314–318. doi: 10.1016/j.prro.2012.01.001 CrossRefPubMedGoogle Scholar
  3. Archambeau JO, Slater JD, Slater JM, Tangeman R (1992) Role for proton beam irradiation in treatment of pediatric CNS malignancies. Int J Radiat Oncol Biol Phys 22(2):287–294CrossRefPubMedGoogle Scholar
  4. Bian SX, McAleer MF, Vats TS, Mahajan A, Grosshans DR (2013) Pilocytic astrocytoma with leptomeningeal dissemination. Childs Nerv Syst 29(3):441–450. doi: 10.1007/s00381-012-1970-y CrossRefPubMedGoogle Scholar
  5. Blattmann H, Coray A, Pedroni E, Greiner R (1990) Spot scanning for 250 MeV protons. Strahlenther Onkol 166(1):45–48PubMedGoogle Scholar
  6. Boehling NS, Grosshans DR, Bluett JB, Palmer MT, Song X, Amos RA, Sahoo N, Meyer JJ, Mahajan A, Woo SY (2012) Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys 82(2):643–652. doi: 10.1016/j.ijrobp.2010.11.027 CrossRefPubMedGoogle Scholar
  7. Eaton BR, Yock T (2014) The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors. Cancer J 20(6):403–408. doi: 10.1097/PPO.0000000000000079 CrossRefPubMedGoogle Scholar
  8. Fossati P, Ricardi U, Orecchia R (2009) Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy. Cancer Treat Rev 35(1):79–96. doi: 10.1016/j.ctrv.2008.09.002 CrossRefPubMedGoogle Scholar
  9. Gunther JR, Sato M, Chintagumpala M, Ketonen L, Jones JY, Allen PK, Paulino AC, Okcu MF, JM S, Weinberg J, Boehling NS, Khatua S, Adesina A, Dauser R, Whitehead WE, Mahajan A (2015) Imaging changes in pediatric intracranial ependymoma patients treated with proton beam radiation therapy compared to intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 93(1):54–63. doi: 10.1016/j.ijrobp.2015.05.018 CrossRefPubMedGoogle Scholar
  10. Hill-Kayser C, Kirk M (2015) Brainstem-sparing craniospinal irradiation delivered with pencil beam scanning proton therapy. Pediatr Blood Cancer 62(4):718–720. doi: 10.1002/pbc.25378 CrossRefPubMedGoogle Scholar
  11. Hirano E, Fuji H, Onoe T, Kumar V, Shirato H, Kawabuchi K (2014) Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for medulloblastoma in childhood. J Radiat Res 55(2):320–327. doi: 10.1093/jrr/rrt112 CrossRefPubMedGoogle Scholar
  12. Howell RM, Giebeler A, Koontz-Raisig W, Mahajan A, Etzel CJ, D’Amelio AM Jr, Homann KL, Newhauser WD (2012) Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiat Oncol 7:116. doi: 10.1186/1748-717X-7-116 CrossRefPubMedPubMedCentralGoogle Scholar
  13. Hug EB, Muenter MW, Archambeau JO, DeVries A, Liwnicz B, Loredo LN, Grove RI, Slater JD (2002) Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 178(1):10–17CrossRefPubMedGoogle Scholar
  14. Indelicato DJ, Flampouri S, Rotondo RL, Bradley JA, Morris CG, Aldana PR, Sandler E, Mendenhall NP (2014) Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol 53(10):1298–1304. doi: 10.3109/0284186X.2014.957414 CrossRefPubMedGoogle Scholar
  15. Jimenez RB, Sethi R, Depauw N, Pulsifer MB, Adams J, McBride SM, Ebb D, Fullerton BC, Tarbell NJ, Yock TI, Macdonald SM (2013) Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Int J Radiat Oncol Biol Phys 87(1):120–126. doi: 10.1016/j.ijrobp.2013.05.017 CrossRefPubMedGoogle Scholar
  16. Johnstone PA, McMullen KP, Buchsbaum JC, Douglas JG, Helft P (2013) Pediatric CSI: are protons the only ethical approach? Int J Radiat Oncol Biol Phys 87(2):228–230. doi: 10.1016/j.ijrobp.2013.05.037 CrossRefPubMedGoogle Scholar
  17. Jones B, Wilson P, Nagano A, Fenwick J, McKenna G (2012) Dilemmas concerning dose distribution and the influence of relative biological effect in proton beam therapy of medulloblastoma. Br J Radiol 85(1018):e912–e918. doi: 10.1259/bjr/24498486 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Kahalley LS, Ris MD, Grosshans DR, Okcu MF, Paulino AC, Chintagumpala M, Moore BD, Guffey D, Minard CG, Stancel HH, Mahajan A (2016) Comparing intelligence quotient change after treatment with proton versus photon radiation therapy for pediatric brain tumors. J Clin Oncol. doi: 10.1200/JCO.2015.62.1383 PubMedPubMedCentralGoogle Scholar
  19. Kuhlthau KA, Pulsifer MB, Yeap BY, Rivera Morales D, Delahaye J, Hill KS, Ebb D, Abrams AN, Macdonald SM, Tarbell NJ, Yock TI (2012) Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol 30(17):2079–2086. doi: 10.1200/JCO.2011.37.0577 CrossRefPubMedPubMedCentralGoogle Scholar
  20. Lassen-Ramshad Y, Petersen JB, Tietze A, Borghammer P, Mahajan A, McGovern SL (2015) Pseudoprogression after proton radiotherapy for pediatric low grade glioma. Acta Oncol 54(9):1701–1702. doi: 10.3109/0284186X.2015.1078498 CrossRefPubMedGoogle Scholar
  21. Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, Maor MH, Woo SY, Cox JD, Smith AR (2005) Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 63(2):362–372. doi: 10.1016/j.ijrobp.2005.01.060 CrossRefPubMedGoogle Scholar
  22. Lin H, Ding X, Kirk M, Liu H, Zhai H, Hill-Kayser CE, Lustig RA, Tochner Z, Both S, McDonough J (2014) Supine craniospinal irradiation using a proton pencil beam scanning technique without match line changes for field junctions. Int J Radiat Oncol Biol Phys 90(1):71–78. doi: 10.1016/j.ijrobp.2014.05.029 CrossRefPubMedGoogle Scholar
  23. Lucas JT Jr, Ladra MM, MacDonald SM, Busse PM, Friedmann AM, Ebb DH, Marcus KJ, Tarbell NJ, Yock TI (2015) Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer 62(9):1523–1528. doi: 10.1002/pbc.25494 CrossRefPubMedGoogle Scholar
  24. Lundkvist J, Ekman M, Ericsson SR, Jonsson B, Glimelius B (2005) Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 103(4):793–801. doi: 10.1002/cncr.20844 CrossRefPubMedGoogle Scholar
  25. Luu QT, Loredo LN, Archambeau JO, Yonemoto LT, Slater JM, Slater JD (2006) Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J 12(2):155–159PubMedGoogle Scholar
  26. Mailhot Vega R, Kim J, Hollander A, Hattangadi-Gluth J, Michalski J, Tarbell NJ, Yock TI, Bussiere M, MacDonald SM (2015) Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children. Cancer 121(10):1694–1702. doi: 10.1002/cncr.29209 CrossRefPubMedGoogle Scholar
  27. Mailhot Vega RB, Kim J, Bussiere M, Hattangadi J, Hollander A, Michalski J, Tarbell NJ, Yock T, MacDonald SM (2013) Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma. Cancer 119(24):4299–4307. doi: 10.1002/cncr.28322 CrossRefPubMedGoogle Scholar
  28. McAllister B, Archambeau JO, Nguyen MC, Slater JD, Loredo L, Schulte R, Alvarez O, Bedros AA, Kaleita T, Moyers M, Miller D, Slater JM (1997) Proton therapy for pediatric cranial tumors: preliminary report on treatment and disease-related morbidities. Int J Radiat Oncol Biol Phys 39(2):455–460CrossRefPubMedGoogle Scholar
  29. McGovern SL, Okcu MF, Munsell MF, Kumbalasseriyil N, Grosshans DR, McAleer MF, Chintagumpala M, Khatua S, Mahajan A (2014) Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system. Int J Radiat Oncol Biol Phys 90(5):1143–1152. doi: 10.1016/j.ijrobp.2014.08.354 CrossRefPubMedPubMedCentralGoogle Scholar
  30. Merchant TE, Hua CH, Shukla H, Ying X, Nill S, Oelfke U (2008) Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 51(1):110–117. doi: 10.1002/pbc.21530 CrossRefPubMedGoogle Scholar
  31. Miralbell R, Lomax A, Cella L, Schneider U (2002) Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 54(3):824–829CrossRefPubMedGoogle Scholar
  32. Mizumoto M, Oshiro Y, Takizawa D, Fukushima T, Fukushima H, Yamamoto T, Muroi A, Okumura T, Tsuboi K, Sakurai H (2015) Proton beam therapy for pediatric ependymoma. Pediatr Int 57(4):567–571. doi: 10.1111/ped.12624 CrossRefPubMedGoogle Scholar
  33. Moeller BJ, Chintagumpala M, Philip JJ, Grosshans DR, McAleer MF, Woo SY, Gidley PW, Vats TS, Mahajan A (2011) Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy. Radiat Oncol 6:58. doi: 10.1186/1748-717X-6-58 CrossRefPubMedPubMedCentralGoogle Scholar
  34. Mohan R, Mahajan A, Minsky BD (2013) New strategies in radiation therapy: exploiting the full potential of protons. Clin Cancer Res 19(23):6338–6343. doi: 10.1158/1078-0432.CCR-13-0614 CrossRefPubMedPubMedCentralGoogle Scholar
  35. Neelima R, Easwer HV, Kapilamoorthy TR, Hingwala DR, Radhakrishnan VV (2012) Embryonal tumor with multilayered rosettes: two case reports with a review of the literature. Neurol India 60(1):96–99. doi: 10.4103/0028-3886.93614 CrossRefPubMedGoogle Scholar
  36. Owusu-Agyemang P, Grosshans D, Arunkumar R, Rebello E, Popovich S, Zavala A, Williams C, Ruiz J, Hernandez M, Mahajan A, Porche V (2014) Non-invasive anesthesia for children undergoing proton radiation therapy. Radiother Oncol. doi: 10.1016/j.radonc.2014.01.016 PubMedGoogle Scholar
  37. Park J, Park Y, Lee SU, Kim T, Choi YK, Kim JY (2015) Differential dosimetric benefit of proton beam therapy over intensity modulated radiotherapy for a variety of targets in patients with intracranial germ cell tumors. Radiat Oncol 10:135. doi: 10.1186/s13014-015-0441-5 CrossRefPubMedPubMedCentralGoogle Scholar
  38. Pulsifer MB, Sethi RV, Kuhlthau KA, MacDonald SM, Tarbell NJ, Yock TI (2015) Early cognitive outcomes following proton radiation in pediatric patients with brain and central nervous system tumors. Int J Radiat Oncol Biol Phys 93(2):400–407. doi: 10.1016/j.ijrobp.2015.06.012 CrossRefPubMedPubMedCentralGoogle Scholar
  39. Ray GL, Buchsbaum JC, McMullen KP, Simoneaux RV, Hines M, Douglas JG, Johnstone PA (2013) Definitive treatment of leptomeningeal spinal metastases in children. Pediatr Blood Cancer 60(11):1839–1841. doi: 10.1002/pbc.24659 CrossRefPubMedGoogle Scholar
  40. Rutz HP, Weber DC, Goitein G, Ares C, Bolsi A, Lomax AJ, Pedroni E, Coray A, Hug EB, Timmermann B (2008) Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at paul scherrer institute. Int J Radiat Oncol Biol Phys 71(1):220–225. doi: 10.1016/j.ijrobp.2007.09.014 CrossRefPubMedGoogle Scholar
  41. Sethi RV, Giantsoudi D, Raiford M, Malhi I, Niemierko A, Rapalino O, Caruso P, Yock TI, Tarbell NJ, Paganetti H, MacDonald SM (2014) Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses. Int J Radiat Oncol Biol Phys 88(3):655–663. doi: 10.1016/j.ijrobp.2013.11.239 CrossRefPubMedGoogle Scholar
  42. St Clair WH, Adams JA, Bues M, Fullerton BC, La Shell S, Kooy HM, Loeffler JS, Tarbell NJ (2004) Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 58(3):727–734. doi: 10.1016/S0360-3016(03)01574-8 CrossRefPubMedGoogle Scholar
  43. Suneja G, Poorvu PD, Hill-Kayser C, Lustig RA (2013) Acute toxicity of proton beam radiation for pediatric central nervous system malignancies. Pediatr Blood Cancer 60(9):1431–1436. doi: 10.1002/pbc.24554 CrossRefPubMedGoogle Scholar
  44. Verma V, Mishra MV, Mehta MP (2016) A systematic review of the cost and cost-effectiveness studies of proton radiotherapy. Cancer. doi: 10.1002/cncr.29882 PubMedCentralGoogle Scholar
  45. Wilson RW (1946) Radiological use of fast protons. Radiology 47(5):487–491CrossRefPubMedGoogle Scholar
  46. Wolden SL (2013) Protons for craniospinal radiation: are clinical data important? Int J Radiat Oncol Biol Phys 87(2):231–232. doi: 10.1016/j.ijrobp.2013.05.036 CrossRefPubMedGoogle Scholar
  47. Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ (2016) Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. doi: 10.1016/S1470-2045(15)00167-9 Google Scholar
  48. Yoon M, Shin DH, Kim J, Kim JW, Kim DW, Park SY, Lee SB, Kim JY, Park HJ, Park BK, Shin SH (2011) Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys 81(3):637–646. doi: 10.1016/j.ijrobp.2010.06.039 CrossRefPubMedGoogle Scholar
  49. Yuh GE, Loredo LN, Yonemoto LT, Bush DA, Shahnazi K, Preston W, Slater JM, Slater JD (2004) Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. Cancer J 10(6):386–390CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Radiation OncologyMayo ClinicRochesterUSA

Personalised recommendations